Nordic Cancer Union Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2000
NCT00376883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Alternative names

Nordic Cancer Union

Active Ingredients

Drugs in Phase 3 Trials (1)

pamidronate (aredia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1